Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa.
Ontology highlight
ABSTRACT: Nebulization is currently used for delivery of antibiotics for respiratory infections. Bacteriophages (or phages) are effective predators of pathogens including Pseudomonas aeruginosa commonly found in the lungs of patients with cystic fibrosis (CF). It is known that phages and antibiotics can potentially show synergistic antimicrobial effect on bacterial killing. In the present study, we investigated synergistic antimicrobial effect of phage PEV20 with five different antibiotics against three P. aeruginosa strains isolated from sputum of CF patients. The antibiotics included ciprofloxacin, tobramycin, colistin, aztreonam and amikacin, which are approved by U.S Food and Drug Administration (FDA) for inhaled administration. Phage and antibiotic synergy was determined by assessing bacterial
SUBMITTER: Lin Y
PROVIDER: S-EPMC6174101 | biostudies-literature | 2018 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA